Triamcinolone Acetonide NDC 21922-024

NDC codes

FDA NDC Directory

Product NDC (as listed)21922-024Labeler and product segments. Claims need a package NDC.

Product NDC at billing width21922-0024Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
21922-024-11	21922002411	430 g in 1 JAR (21922-024-11)Marketed from Dec 2, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide ointment usp, 0.05%
Active ingredients: Triamcinolone acetonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Encube Ethicals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212384
Marketing start: Dec 2, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 21922-024_ddea3294-169f-4a9d-865f-96f0f65f690bSPL ID ddea3294-169f-4a9d-865f-96f0f65f690bSPL set ID a20baaac-002d-40ac-9c7b-f92e8ee987eaRxCUI 1090641UNII F446C597KAUPC 0321922024111
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N421922002411 followed by a unit qualifier and the quantity

Package 21922-0024-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 25, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Triamcinolone Acetonide Ointment 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212384

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212384
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonidetriamcinolone acetonide ointment usp, 0.05%	Triamcinolone acetonide .5 mg/g	OintmentTopical	Northstar Rx LLC	72603-319